Literature DB >> 25375918

Colorectal cancer classification based on gene expression is not associated with FOLFIRI response.

Raquel Martinez-Garcia1, Pedro P Lopez-Casas1, Daniel Rico2, Alfonso Valencia2, Manuel Hidalgo1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25375918     DOI： 10.1038/nm.3701

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.

Authors:  Maguy Del Rio; Franck Molina; Caroline Bascoul-Mollevi; Virginie Copois; Frédéric Bibeau; Patrick Chalbos; Corinne Bareil; Andrew Kramar; Nicolas Salvetat; Caroline Fraslon; Emmanuel Conseiller; Virginie Granci; Benjamin Leblanc; Bernard Pau; Pierre Martineau; Marc Ychou
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

2.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440
  2 in total
  5 in total

1.  Reply to Colorectal cancer classification based on gene expression is not associated with FOLFIRI response.

Authors:  Anguraj Sadanandam; Joe Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2014-11       Impact factor: 53.440

Review 2.  Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges.

Authors:  Joyce Y Buikhuisen; Arezo Torang; Jan Paul Medema
Journal:  Oncogenesis       Date:  2020-07-09       Impact factor: 7.485

Review 3.  Understanding cell-cell communication and signaling in the colorectal cancer microenvironment.

Authors:  Shaikha AlMusawi; Mehreen Ahmed; Abdolrahman S Nateri
Journal:  Clin Transl Med       Date:  2021-02

4.  Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.

Authors:  Ying Bao; Yongliang Lu; Xiang Wang; Wenming Feng; Xinrong Sun; Huihui Guo; Chengwu Tang; Xiaojing Zhang; Qilin Shi; Hongbin Yu
Journal:  Cancer Cell Int       Date:  2015-11-17       Impact factor: 5.722

5.  Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.

Authors:  Yongjun Cha; Kyung-Ju Kim; Sae-Won Han; Ye Young Rhee; Jeong Mo Bae; Xianyu Wen; Nam-Yun Cho; Dae-Won Lee; Kyung-Hun Lee; Tae-Yong Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Seung-Yong Jeong; Kyu Joo Park; Gyeong Hoon Kang; Tae-You Kim
Journal:  Br J Cancer       Date:  2016-06-16       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.